Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Amphastar Plans To Launch Second OTC Product Also In Emergency Medicine Category

May 29 2024

• By Malcolm Spicer

• Source: Shutterstock

Related Content

Green Light For First OTC Naloxone In US After FDA Raises Caution Flag During Advisory Panel

Mar 30 2023

OTC Primatene Mist Returns: Market Future Bright After Cloudy NDA History

Nov 10 2018

HRT Prioritizes Access To Affordable Naloxone As US FDA Approves Second OTC Formulation

Jul 28 2023

US Needs OTC Inhalers For Asthma Treatment, And FDA Should Force A Switch, Researchers Say

Apr 06 2022

Related Companies

Amphastar Pharmaceuticals, Inc.

Emergent BioSolutions, Inc.

Amneal Pharmaceuticals, Inc.

Additional Topics

International United States OTC Drugs Prescription To OTC Switch Sales & Earnings Advertising, Marketing & Sales Business Strategies Commercial Companies Consumer Distribution Drug Approval Standards FDA Ingredients Launches Manufacturing Policy Regulation Retail

More from Rx-to-OTC Switch

More from Health

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window